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Take home message: TGFBR2 mutations that cause Loeys-Dietz Syndrome can 
present as pneumothorax.  In vitro kinase assays can help 
confirm pathogenicity of novel variants.  
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To the Editor: 
Primary pneumothorax affects 0.01% of the population.  Ten per-cent of cases have a 
family history of pneumothorax, but in the majority a definitive genetic diagnosis is not 
made.  We report a 26-year old white British woman who presented with left apical 
pneumothorax (Fig 1A). Previously, she had migraines, multiple stress fractures in 
her right foot, myopia, easy bruising, lumbar scoliosis and spontaneous dislocation of 
the right patella. She had no previous history of pneumothoraces or any other 
respiratory problems, and had never smoked.  
 
On examination she was hypermobile (Beighton score 7/9), had facial milia, 
translucent hyperextensible skin, striae over her back, chest wall asymmetry, bilateral 
varicose veins and pes planus.  Her uvula was bifid (Fig 1B), she had a high arched 
palate with dental crowding and her arm-span-to-height ratio was increased (1.14).  In 
the ophthalmology clinic, lattice dystrophy (weakness in the peripheral retina 
predisposing to retinal detachment) was identified with no ocular features of Marfan 
syndrome. The patient’s thoracic CT revealed apical blebs and her echocardiogram 
and CT showed aortic root dilatation (3.54 cm, Z-score > 2) (Fig 1C-D).  Her 59-year 
old mother, who had not suffered pneumothoraces, was reviewed and found to have 
mild features of a connective tissue disorder: skin hyperextensibility, joint 
hypermobility with Beighton scale score of 5/9, high-arched palate, mild thoracic 
kyphosis, easy bruising, recurrent left shoulder dislocation, hiatus hernia, stress 
incontinence, and stress fractures of left foot. 
These findings led to the clinical diagnosis of Loeys-Dietz Syndrome (LDS), an 
autosomal dominant disorder affecting the TGF-ß signalling pathway (1).  LDS 
(LDS1-5; OMIM #609192, #610168, #613795, #614816, #615582) is characterized by 
vascular findings (cerebral, thoracic, and abdominal arterial aneurysms/dissections) 
and skeletal manifestations (pectus excavatum or pectus carinatum, scoliosis, joint 
laxity, arachnodactyly, talipes equinovarus). Approximately 75% of affected 
individuals have LDS type I with craniofacial manifestations (hypertelorism, bifid 
uvula/cleft palate, craniosynostosis); approximately 25% have LDS type II with 
systemic manifestations of LDSI but minimal or absent craniofacial features. LDSI 
and LDSII form a clinical continuum. The natural history of LDS is characterized by 
aggressive arterial aneurysms (mean age at death 26.1 years) and a high incidence 
of pregnancy-related complications, including death and uterine rupture. The 
diagnosis of LDS is based on characteristic clinical findings in the proband and family 
members and molecular genetic testing of TGFBR1, TGFBR2, SMAD3, TGFB2 and 
TGFB3. 
Other connective tissue disorders such as Marfan syndrome were not considered 
likely, especially with the clinical findings of facial milia and bifid uvula, as these are 
specific to LDS. Her TGFBR1 and TGFBR2 genes were sequenced from leucocyte-
derived DNA and she was found to be heterozygous for a novel missense variant of 
the TGFBR2 gene (c.1262C>A; threonine 421 to asparagine: p.Thr421Asn; reference 
sequence NM_003242.5; Fig 1E).  Subsequent testing found her mother to be a low-
level mosaic for this variant. 
 
The pathogenicity of novel missense variants of disease-associated genes is often 
uncertain.  The threonine at position 421 is a highly conserved residue within the 
protein kinase domain of TGFBRII.  In silico analysis of the identified variant using 
SIFT and Polyphen suggested pathogenicity with SIFT predicting the change to affect 
protein function and Polyphen predicting the change to be damaging. This variant is 
neither listed on the HGMD database nor the ExAC (Exome Aggregation Consortium) 
database.  
 
There is no crystal structure available for the TGFBRII protein; however, based on a 
structure of the homologous activin receptor ActRIIB (47.57% identity within their 
kinase domains: TGFBRII residues 244-544 and ActRIIB residues 190-480), we 
assessed the interactions in this highly-conserved region.  This predicted the new 
mutation would disrupt an intramolecular hydrogen bond stabilising the highly 
conserved kinase activation loop and so affect activity (Fig 1F). Effects upon folding 
could not be excluded by this approach though we considered this unlikely.  We 
therefore assessed the folding and function of the new variant.  Human Embryonic 
Kidney (HEK) 293T cells were transiently transfected with expression vectors 
encoding TGFBRII proteins: wild-type (WT), the new T421N mutant, and a known 
kinase-dead R528C mutant (2).  Protein lysates were either left untreated or digested 
with EndoH, which digests immature glycans on proteins within the endoplasmic 
reticulum, or PNGase, which removes all N-linked glycans regardless of their 
complexity.  Lysates were then subjected to SDS-PAGE, transferred to nitrocellulose 
and immunoblotted for TGFBRII.  The T421N variant expressed well in cultured 
mammalian cells and, similar to the known inactive R528C mutant, displayed a 
mature glycosylation pattern suggesting it was well folded and had exited the 
endoplasmic reticulum (Fig 1G).   
 
It is known that mutants of TGFBRII exist that lack normal kinase activity but traffic 
normally (2).  We therefore purified TGFBRII wild-type protein, the T421N variant and 
the kinase-deficient variant, R528C.  HEK293T cells were transiently transfected with 
expression vectors encoding TGFBRII proteins tagged on their C-termini with FLAG: 
wild-type (WT), T421N, R528C, and a weak hypomorphic variant V387M (our 
unpublished observation).  Cells were lysed and FLAG-tagged proteins purified by 
immunoprecipitation.  After elution from the antibody using FLAG peptide, one third of 
the material was incubated with [γ32P]-ATP for 30 minutes at 30˚C then separated by 
SDS-PAGE and exposed to a phosphorimager plate.  As expected, the positive 
control wild-type TGFBRII autophosphorylated strongly, while the negative control 
R528C did not (upper panel Fig 1H).  The novel T421N mutant also showed impaired 
autophosophorylation, indicating it to be pathogenic and confirming the clinical 
diagnosis of Loeys-Dietz syndrome.  Since radiolabelling does not lend itself well to 
clinical laboratory practice, we also examined unlabelled proteins by Phos-tag gel 
followed by immunoblotting.  This technique separates proteins both by their size and 
by degree of phosphorylation (3).  Once again, the positive and negative controls 
separated well and the T421N mutant showed a clear reduction of 
autophosphorylation (lower panel Fig 1H).  
 
The precise mechanism by which haploinsufficiency for TGFBR2 leads to disease is 
unclear, but in mice, deficiency of TGFBR2 in cranial neural crest cells leads to 
elevated expression of TGF-ß2 and TGF-ß receptor III (4).  This increases SMAD-
independent downstream signalling leading to defective proliferation of palatal 
mesenchyme and may account for the craniofacial defects observed in LDS.   
 
Although one review has noted pneumothoraces in cases of known LDS (5), to our 
knowledge, this is the first documented case of LDS to present with pneumothorax.  
We have confirmed the causative mutation to be a kinase-dead allele of TGFBR2 by 
developing both radioactive and non-radioactive assays for TGFRII autokinase 
activity.  As the identification of multiple variants, either through targeted gene 
analysis or through panel testing of large numbers of genes, becomes routine, such in 
vitro techniques for the functional characterisation and validation of putative disease-
causing mutations will be increasingly important.  LDS should be considered as a 
monogenic cause of pneumothorax in addition to the more widely appreciated 
causes: Marfan Syndrome, vascular Ehlers-Danlos Syndrome, Tuberous Sclerosis/ 
Lymphangioleiomyomatosis (LAM) and Birt-Hogg-Dube Syndrome (6).   
 
Our patient’s pneumothorax was treated conservatively and resolved.  There have 
been no further pneumothoraces during the subsequent 3 years.  She was 
commenced on losartan and propranolol as aortic protection and we continue to 
monitor her aortic root diameter.  In conclusion, we describe a case of LDS 
presenting as spontaneous pneumothorax, which illustrates the growing challenges of 
functional validation in the genomic era, as well as enriching the phenotypic spectrum 
of known genetic disorders and demonstrating overlap with related disorders. 
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Legend: 
(A) Chest radiograph demonstrating left apical pneumothorax.   
(B) Photograph of patient’s uvula.   
(C) Coronal reformat of CT chest (lung windows) black arrows showing numerous 
subpleural blebs at both apices 
(D) Sagittal reformat of contrast enhanced CT scan of thoracic aorta.  Black lines 
shows maximal dimensions of the aortic root at the Sinuses of Valsalva (3.54 cm) 
confirmed by ecocardiography and sinotubular junction (2.93 cm). 
(E) Chromatogram of sequence in the region of the c.1262C>A; p.Thr421Asn 
mutation (arrowhead).  
(F) Mutation site (zoomed) modelled on crystal structure (PDB ID 2QLU) of activin 
receptor 2b (ActR2B).  Whole domain and zoom on mutation site.  Residue 
numbering given in form ActR2B/TGFBR2.  The mutation site occurs within the 
activation loop (orange) of the molecule that is critical for regulation of substrate 
binding and kinase activity.  Thr361/421 forms a hydrogen bond (dashed line) with 
Lys323/381.  Its perturbation would therefore destabilise the conformational 
behaviour of the activation loop.   
(G) Protein glycosylation.  Endo H and PNGase digestion of TGFBRII protein.  
Human Embryonic Kidney (HEK) 293T cells were transiently transfected with 
expression vectors encoding TGFBR2 proteins, wild-type (WT), the new T421N 
mutant, and a known kinase-dead R528C mutant.  Protein lysate was either left 
untreated or digested with EndoH or PNGase.  Mature glycosylation is indicated by 
arrow 1; immature glycosylation (endoplasmic reticulum form) by arrow 2; fully 
deglycosylated form arrow 3.  Note the majority of each protein is resistant to Endo H 
digestion indicating glycan processing within the Golgi apparatus.   
(H) Protein autophosphorylation.  HEK293T cells were transiently transfected with 
expression vectors encoding FLAG-tagged TGFBRII proteins: wild-type (WT), T421N, 
R528C, and V387M.  Cells were lysed and FLAG proteins purified by 
immunoprecipitation.  After elution with FLAG peptide, one third of the material was 
incubated with 1µCi of [γ32P]-ATP for 30 minutes at 30˚C then separated by SDS-
PAGE.  Equal amounts of remaining eluate were subjected to SDS-PAGE or phos-tag 
SDS-PAGE, transferred to nitrocellulose membrane and immunoblotted for FLAG.  
Arrow 4 identifies a slowly migrating phosphorylated species, while arrow 5 indicates 
a rapidly migrating poorly-phosphorylated species.   
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